I S ROPER LIMITED
Company number 14284087 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
I S ROPER LIMITED - Analysis Report
Company Number: 14284087
Analysis Date: 2025-07-29 20:11 UTC
Financial Health Assessment for I S ROPER LIMITED
1. Financial Health Score: B-
Explanation:
I S ROPER LIMITED exhibits foundational financial stability typical of a newly incorporated small private company. The presence of positive net current assets and positive shareholders' funds suggests a "healthy cash flow" and working capital position at this early stage. However, given limited operational history (first year of accounts) and modest asset base, the company is at an early development phase with inherent growth risks. The absence of detailed income statement data limits full profitability insight, which tempers the score.
2. Key Vital Signs:
| Metric | Value (£) | Interpretation |
|---|---|---|
| Current Assets | 29,788 | Adequate short-term resources, including cash and receivables. |
| Cash at Bank | 9,795 | Reasonable cash reserve for operating expenses. |
| Debtors (Trade + Other) | 19,993 | Indicates active sales or services provided on credit. |
| Current Liabilities | 22,233 | Obligations due within one year, mainly tax/social security. |
| Net Current Assets | 7,555 | Positive working capital; "healthy financial pulse." |
| Shareholders’ Funds | 7,555 | Equity base supports solvency; no accumulated losses. |
| Employees | 1 | Very small operation, low fixed costs. |
| Company Age | ~1 year | Early stage, limited financial history. |
Additional Notes:
- Taxation and social security form the bulk of current liabilities (£20,662), suggesting timely attention to statutory obligations.
- The company qualifies for audit exemption and follows small company regulations, reflecting its size and scale.
- Directors are closely involved, with two significant controllers holding equal shares and voting rights, implying clear governance but also concentration risks.
3. Diagnosis:
I S ROPER LIMITED’s financial "vital signs" reflect a business with stable liquidity and solvency in its first year of operations. The positive net current assets and shareholders’ funds show that the company can cover short-term debts and has a buffer for operational needs—akin to a patient with a stable heart rate and normal blood pressure.
The significant component of current liabilities being tax and social security indicates the company is meeting statutory obligations but needs to carefully manage cash flow to avoid late payments, which could be a "symptom of distress" if unchecked.
Since the company’s turnover and profitability data are not disclosed, the financial health assessment relies on balance sheet strength and working capital. The absence of debt or long-term liabilities is encouraging, but the company remains vulnerable to external shocks due to its small size and limited operational history.
4. Recommendations:
- Improve Cash Flow Monitoring: Maintain vigilant oversight of cash inflows and outflows. Given the reliance on trade debtors, prompt collection will ensure liquidity remains "healthy."
- Tax Planning: Proactively manage tax payments to avoid penalties or cash crunches associated with statutory liabilities, which currently dominate short-term debt.
- Growth Strategy: Develop plans to scale revenues to strengthen retained earnings and build a more robust equity base—this will improve resilience and financial "immune response."
- Financial Reporting: Consider preparing a full income statement and cash flow report for internal use to better monitor profitability and operating performance.
- Risk Diversification: Since ownership and control are concentrated, consider governance measures to mitigate risks from single points of failure in management.
- Build Financial Reserves: Aim to increase cash reserves beyond current modest levels to buffer against unforeseen expenses or market downturns.
- Explore Funding Options: If growth plans require capital injection, investigate external funding sources such as loans or equity investment to support expansion without jeopardizing liquidity.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.